Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase EARLY_PHASE1 4Phase 3 3Phase 1 3Phase 2 2Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Completed 18Recruiting 11Unknown 6Not yet recruiting 6Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Conditions

Breast Neoplasms 219Neoplasms 177Lung Neoplasms 92Prostatic Neoplasms 89Colorectal Neoplasms 88Carcinoma, Non-Small-Cell Lung 48Stomach Neoplasms 45Motor Activity 45Carcinoma, Hepatocellular 45Pancreatic Neoplasms 40Uterine Cervical Neoplasms 39Anxiety Disorders 39Rectal Neoplasms 34Head and Neck Neoplasms 31Colonic Neoplasms 30Pain 26Depression 26Brain Neoplasms 25Polycystic Ovary Syndrome 24Esophageal Neoplasms 24Disease 23Multiple Myeloma 22Hematologic Neoplasms 22Endometrial Neoplasms 22Ovarian Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Urinary Bladder Neoplasms 18Pain, Postoperative 18Glioblastoma 18Liver Neoplasms 17

Interventions

telitacicept 2talquetamab 1Psychodrama 1Population Groups 1Art Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × Myasthenia Gravis × Clear all
NCT07593911 2026-05-18

ArchAid-002

Beijing GoBroad Hospital

Phase NA Not yet recruiting
75 enrolled

Immunoglobulin G4-Related Disease, Arthritis, Rheumatoid, Lupus Nephritis, Multiple Sclerosis, Myasthenia Gravis

NCT07499323 2026-04-08

Talquetamab in Patients With Refractory Generalized Myasthenia Gravis

First Affiliated Hospital of Chongqing Medical University

Phase NA Not yet recruiting
2 enrolled

Myasthenia Gravis

NCT07298928 2026-03-06

A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis

The Children's Hospital of Zhejiang University School of Medicine

Phase NA Not yet recruiting
30 enrolled

Myasthenia Gravis

NCT07323316 2026-01-07

HARMONY 360

Ad scientiam

Phase NA Not yet recruiting
100 enrolled

Myasthenia Gravis

NCT07125105 2025-08-15

APART-MG

Universite du Littoral Cote d'Opale

Phase NA Not yet recruiting
102 enrolled

Myasthenia Gravis

NCT06827587 2025-02-14

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase NA Not yet recruiting
60 enrolled

Autoimmune Diseases, Myasthenia Gravis, Neuromuscular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡